Page 154 - 南京医科大学学报自然科学版
P. 154

第42卷第5期
               ·750 ·                            南 京    医 科 大 学 学         报                        2022年5月


                   9(6):391-400                                      Biochem,2019,120(3):2756-2765
             [13] AMARAL E P,VINHAES C L,OLIVEIRA⁃DE⁃SOUZA      [26] KHAN A,SINGH V K,HUNTER R L,et al. Macrophage
                   D,et al. The interplay between systemic inflammation,ox⁃  heterogeneity and plasticity in tuberculosis[J]. J Leuko⁃
                   idative stress,and tissue remodeling in tuberculosis[J].  cyte Biol,2019,106(2):275-82
                   Antioxid Redox Signal,2021,34(6):471-485     [27] LUGO⁃VILLARINO G,TROEGELER A,BALBOA L,et
             [14] PIOTROWSKI I,KULCENTY K,SUCHORSKA W. Inter⁃        al. The C⁃type lectin receptor DC⁃SIGN has an anti⁃in⁃
                   play between inflammation and cancer[J]. Rep Pract On⁃  flammatory role in human M(IL ⁃ 4)macrophages in re⁃
                   col Radiother,2020,25(3):422-427                  sponse to Mycobacterium tuberculosis[J]. Front Immu⁃
             [15] GALADARI S,RAHMAN A,PALLICHANKANDY S,et            nol,2018,9:1123
                   al. Reactive oxygen species and cancer paradox:to pro⁃  [28] YAN X,LI W,PAN L,et al. Lewis lung cancer cells pro⁃
                   mote or to suppress?[J]. Free Radical Biol Med,2017,  mote SIGNR1(CD209b)⁃mediated macrophages polariza⁃
                   104:144-164                                       tion induced by IL⁃4 to facilitate immune evasion[J]. J
             [16] SOMASUNDARAM V,BASUDHAR D,BHARADWAJ G,             Cell Biochem,2016,117(5):1158-1166
                   et al. Molecular mechanisms of nitric oxide in cancer pro⁃  [29] LI R,RÜTTINGER D,LI R,et al. Analysis of the immu⁃
                   gression,signal transduction,and metabolism[J]. Antiox⁃  nological microenvironment at the tumor site in patients
                   id Redox Signal,2019,30(8):1124-1143              with non ⁃ small cell lung cancer[J]. Langenbecks Arch
             [17] CHAI Q,LU Z,LIU Z,et al. Lung gene expression signa⁃  Surg,2003,388(6):406-412
                   tures suggest pathogenic links and molecular markers for  [30] 温少迪,沈  波. 非小细胞肺癌免疫治疗作用机制及临
                   pulmonary tuberculosis,adenocarcinoma and sarcoidosis  床研究现状[J]. 南京医科大学学报(自然科学版),
                  [J]. Commun Biol,2020,3(1):604                     2020,40(11):1739-1746
             [18] COSTA C,INCIO J,SOARES R. Angiogenesis and chron⁃  [31] WU X,GU Z,CHEN Y,et al. Application of PD⁃1 block⁃
                   ic inflammation:cause or consequence?[J]. Angiogene⁃  ade in cancer immunotherapy[J]. Comput Struct Biotech⁃
                   sis,2007,10(3):149-166                            nol J,2019,17:661-674
             [19] WALTON E M,CRONAN M R,CAMBIER C,et al. Cyclo⁃  [32] SUAREZ G V,MELUCCI GANZARAIN C D C,VECCHI⁃
                   propane modification of trehalose dimycolate drives granu⁃  ONE M B,et al. PD⁃1/PD⁃L1 pathway modulates macro⁃
                   loma angiogenesis and mycobacterial growth through vegf  phage susceptibility to mycobacterium tuberculosis specif⁃
                   signaling[J]. Cell Host Microbe,2018,24(4):514-25. e6  ic CD8(+)T cell induced death[J]. Sci Rep,2019,9(1):
             [20] GUPTA P K,TRIPATHI D,KULKARNI S,et al. Myco⁃       187
                   bacterium tuberculosis H37Rv infected THP ⁃ 1 cells in⁃  [33] KAMBOJ D,GUPTA P,BASIL M V,et al. Improved My⁃
                   duce epithelial mesenchymal transition(EMT)in lung ad⁃  cobacterium tuberculosis clearance after the restoration of
                   enocarcinoma epithelial cell line(A549)[J]. Cell Immu⁃  IFN⁃gamma(+)TNF⁃alpha(+)CD4(+)T cells:Impact of
                   nol,2016,300:33-40                                PD⁃1 inhibition in active tuberculosis patients[J]. Eur J
             [21] QIANG L,WANG J,ZHANG Y,et al. Mycobacterium tu⁃    Immunol,2020,50(5):736-747
                   berculosis Mce2E suppresses the macrophage innate im⁃  [34] ZAEMES J,KIM C. Immune checkpoint inhibitor use and
                   mune response and promotes epithelial cell proliferation  tuberculosis:a systematic review of the literature[J]. Eur
                  [J]. Cell Mol Immunol,2019,16(4):380-391           J Cancer,2020,132:168-175
             [22] DUAN M C,ZHONG X N,LIU G N,et al. The Treg/Th17  [35] LAZAR⁃MOLNAR E,CHEN B,SWEENEY K A,et al.
                   paradigm in lung cancer[J]. J Immunol Res,2014,2014:  Programmed death⁃1(PD⁃1)⁃deficient mice are extraordi⁃
                   730380                                            narily sensitive to tuberculosis[J]. Proc Natl Acad Sci U
             [23] LI Q,ZHANG H,YU L,et al. Down⁃regulation of Notch  S A,2010,107(30):13402-13407
                   signaling pathway reverses the Th1/Th2 imbalance in tu⁃  [36] BAE S,KIM Y J,KIM M J,et al. Risk of tuberculosis in
                   berculosis patients[J]. Int Immunopharmacol,2018,54:  patients with cancer treated with immune checkpoint in⁃
                   24-32                                             hibitors:a nationwide observational study[J]. J immuno⁃
             [24] ZHOU Y,HU Z,CAO S,et al. Concomitant Mycobacteri⁃  ther cancer,2021,9(9):e002960
                   um tuberculosis infection promotes lung tumor growth  [37] ZHENG L,YIN J,WANG S,et al. Associated factors of co
                   through enhancing Treg development[J]. Oncol Rep,  ⁃existent pulmonary tuberculosis and lung cancer:a case⁃
                   2017,38(2):685-692                                control study[J]. Eur J Clin Invest,2021,51(4):e13432
                                                                                           18
             [25] NAJAFI M,HASHEMI GORADEL N,FARHOOD B,et       [38] GU J,REN Y,CHEN X,et al. F⁃FDG PET/CT manifes⁃
                   al. Macrophage polarity in cancer:A review[J]. J Cell                        (下转第758页)
   149   150   151   152   153   154   155   156   157   158   159